A. G. Konoplyannikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
A. G. Konoplyannikov has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
E. V. Agaeva
Ministry of Health of the Russian Federation
3 shared publicationsI. V. Semenkova
Ministry of Health of the Russian Federation
3 shared publicationsA. F. Tsyb
Medical Radiological Research Center, Russian Academy of Medical Sciences, Obninsk, Russia
2 shared publications- Av Vyacheslavovich Averyanov
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies FMBA of Russia
2 shared publications L. A. Lepechina
Medical Radiological Research Center, Russian Academy of Medical Sciences, Obninsk, Russia
2 shared publications- Mikhail A. Konoplyannikov
ФГБУ ФНКЦ ФМБА России
2 shared publications
Latest Publications
- Open Access
- 30 January 2018
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 19 (4) , 88-96
Effects of inhalation and intravenous administration of allogeneic mesenchymal bone marrow stromal cells in a bleomycin-induced model of pulmonary fibrosis in rabbits
Aim:to perform a comparative analysis of the effi cacy of the inhaled and intravenous delivery of equivalent doses of bone marrow mesenchymal stem cells (BMMSCs) in rabbits according to the standard model of bleomycin pulmonary fi brosis.Materials and methods.After bronchoscopic instillation of bleomycin, 5 rabbits received intravenous transplantation of 2 × 106 allogeneic BMMSCs, other 5 rabbits – 2 × 107 MSCs inhaled via compressor nebulizer; control healthy and bleomycin group included 5 animals each.Results.Both groups treated with BMMSCs had a signifi cantly lower Ashcroft fi brosis index than the bleomycin control group. Expression of collagen in lung tissue in all groups with bleomycin injury was superior to healthy controls, but in animals underwent intravenous BMMSC transplantation collagen score was 0.74 points, and in inhaled treated group – 0.51 points, while in bleomycin controls – 2.1 point. Levels of TNF-α and TGF-β1 in BAL fl uids tended to decrease in treatment groups, but did not differ signifi cantly from control. A similar picture was observed in the cytological analysis of BAL.Conclusion.In general, both methods of delivering of BMMSCs to the lungs demonstrated similar therapeutic effects in inhibiting the development of experimental fi brosis, indicating that both intravenous and inhalational way of introduction can be used for subsequent clinical studies.
- 30 January 2018
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 19 (4) , 88-96
Open AccessEffects of inhalation and intravenous administration of allogeneic mesenchymal bone marrow stromal cells in a bleomycin-induced model of pulmonary fibrosis in rabbits
Aim:to perform a comparative analysis of the effi cacy of the inhaled and intravenous delivery of equivalent doses of bone marrow mesenchymal stem cells (BMMSCs) in rabbits according to the standard model of bleomycin pulmonary fi brosis.Materials and methods.After bronchoscopic instillation of bleomycin, 5 rabbits received intravenous transplantation of 2 × 106 allogeneic BMMSCs, other 5 rabbits – 2 × 107 MSCs inhaled via compressor nebulizer; control healthy and bleomycin group included 5 animals each.Results.Both groups treated with BMMSCs had a signifi cantly lower Ashcroft fi brosis index than the bleomycin control group. Expression of collagen in lung tissue in all groups with bleomycin injury was superior to healthy controls, but in animals underwent intravenous BMMSC transplantation collagen score was 0.74 points, and in inhaled treated group – 0.51 points, while in bleomycin controls – 2.1 point. Levels of TNF-α and TGF-β1 in BAL fl uids tended to decrease in treatment groups, but did not differ signifi cantly from control. A similar picture was observed in the cytological analysis of BAL.Conclusion.In general, both methods of delivering of BMMSCs to the lungs demonstrated similar therapeutic effects in inhibiting the development of experimental fi brosis, indicating that both intravenous and inhalational way of introduction can be used for subsequent clinical studies.
- 15 September 2015
- Published by Pleiades Publishing Ltd in Crystallography Reports
- Vol. 60 (5) , 763-767
Detonation nanodiamond complexes with cancer stem cells inhibitors or paracrine products of mesenchymal stem cells as new potential medications
- 15 September 2015
- Published by Pleiades Publishing Ltd in Crystallography Reports
- Vol. 60 (5) , 763-767
Detonation nanodiamond complexes with cancer stem cells inhibitors or paracrine products of mesenchymal stem cells as new potential medications
- 1 January 2015
- Published by Akademizdatcenter Nauka in Kristallografiâ
- Vol. 60 (5) , 831-836
Комплексы детонационных наноалмазов с ингибиторами раковых стволовых клеток или с паракринными продуктами мезенхимальных стволовых клеток как новые потенциальные лекарственные средства
Совместное применение комплексов наиболее активных химиопрепаратов и детонационных наноалмазов (ДНА) является новым направлением в терапии раковых заболеваний, что, по-видимому, связано с избирательно
- 1 January 2015
- Published by Akademizdatcenter Nauka in Kristallografiâ
- Vol. 60 (5) , 831-836
Комплексы детонационных наноалмазов с ингибиторами раковых стволовых клеток или с паракринными продуктами мезенхимальных стволовых клеток как новые потенциальные лекарственные средства
Совместное применение комплексов наиболее активных химиопрепаратов и детонационных наноалмазов (ДНА) является новым направлением в терапии раковых заболеваний, что, по-видимому, связано с избирательно
- 1 May 2014
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 157 (1) , 143-145
Allogenic Cardiomyoblasts Raised from Human Mesenchymal Stem Cells in the Therapy of Radiation Cardiomyopathy and Pericarditis: Case Report
The use of triple systemic transplantation of cardiomyoblasts raised from the culture of allogenic bone marrow mesenchymal stem cells of a healthy donor according to the new medical technology licensed by Federal Service on Surveillance in Healthcare in the therapy of a patient with late radiation cardiomyopathy and radiation exudative pericarditis developed 45 years after radiation therapy for Hodgkin lymphoma. High efficiency of systemic transplantation of mesenchymal stem cells partially differentiated towards cardiomyocytes was demonstrated. The therapeutic effect persists for more than 2 years. Possible mechanisms of the therapeutic effect of this type of stem cells and the prospects of using cell therapy in the treatment of late radiation injuries of vital organs and tissues are discussed.
- 1 May 2014
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 157 (1) , 143-145
Allogenic Cardiomyoblasts Raised from Human Mesenchymal Stem Cells in the Therapy of Radiation Cardiomyopathy and Pericarditis: Case Report
The use of triple systemic transplantation of cardiomyoblasts raised from the culture of allogenic bone marrow mesenchymal stem cells of a healthy donor according to the new medical technology licensed by Federal Service on Surveillance in Healthcare in the therapy of a patient with late radiation cardiomyopathy and radiation exudative pericarditis developed 45 years after radiation therapy for Hodgkin lymphoma. High efficiency of systemic transplantation of mesenchymal stem cells partially differentiated towards cardiomyocytes was demonstrated. The therapeutic effect persists for more than 2 years. Possible mechanisms of the therapeutic effect of this type of stem cells and the prospects of using cell therapy in the treatment of late radiation injuries of vital organs and tissues are discussed.
- Open Access
- 15 December 2010
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 1 (4) , 3-11
CELLULAR TECHNOLOGIES IN TREATMENT OF LUNG DISEASES – ARE WHETHER PROSPECTS?
In the article the problem of treatment of lung pathology by cellular technologies is analyzed. Results of experiments, giving hopes for positive outcomes of clinical trials are summarized. Possible mechanisms of influence stem cells on regenerative processes in lungs are considered.
- 15 December 2010
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 1 (4) , 3-11
Open AccessCELLULAR TECHNOLOGIES IN TREATMENT OF LUNG DISEASES – ARE WHETHER PROSPECTS?
In the article the problem of treatment of lung pathology by cellular technologies is analyzed. Results of experiments, giving hopes for positive outcomes of clinical trials are summarized. Possible mechanisms of influence stem cells on regenerative processes in lungs are considered.
- 1 October 2008
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 146 (4) , 540-542
Role of Cyclooxygenases in the Stimulatory Effect of Carcinogen 1,2-Dimethylhydrazine on Stem Cell Survival in the Intestinal Epithelium and Bone Marrow
- 1 October 2008
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 146 (4) , 540-542
Role of Cyclooxygenases in the Stimulatory Effect of Carcinogen 1,2-Dimethylhydrazine on Stem Cell Survival in the Intestinal Epithelium and Bone Marrow
- 1 July 2008
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 146 (1) , 158-164
In vitro inhibitory effect of mesenchymal stem cells on zymosan-induced production of reactive oxygen species
In vitro chemiluminescent test showed that human bone marrow mesenchymal stem cells and conditioned media dose-dependently inhibit production of reactive oxygen species by macrophages: 50% inhibition of chemiluminescence (compared to biocontrol) was observed at 1:1 mesenchymal stem cell/macrophage ratio or after addition of 20–25% conditioned media to the incubation medium. The observed mechanism of inhibition of production of reactive oxygen forms can play an essential role in the formation of local immunosuppressive microenvironment in the organism after allogenic transplantation of mesenchymal stem cells.
- 1 July 2008
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 146 (1) , 158-164
In vitro inhibitory effect of mesenchymal stem cells on zymosan-induced production of reactive oxygen species
In vitro chemiluminescent test showed that human bone marrow mesenchymal stem cells and conditioned media dose-dependently inhibit production of reactive oxygen species by macrophages: 50% inhibition of chemiluminescence (compared to biocontrol) was observed at 1:1 mesenchymal stem cell/macrophage ratio or after addition of 20–25% conditioned media to the incubation medium. The observed mechanism of inhibition of production of reactive oxygen forms can play an essential role in the formation of local immunosuppressive microenvironment in the organism after allogenic transplantation of mesenchymal stem cells.
- 1 April 2008
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 145 (4) , 520-525
Effects of 60Co whole-body γ-irradiation in different doses on the distribution of 188Re-labeled autologous mesenchymal stem cells in Wistar rats after intravenous (systemic) transplantation during different periods after exposure
- 1 April 2008
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 145 (4) , 520-525
Effects of 60Co whole-body γ-irradiation in different doses on the distribution of 188Re-labeled autologous mesenchymal stem cells in Wistar rats after intravenous (systemic) transplantation during different periods after exposure
- 25 October 2002
- Vol. 42 (4) , 395-8
[Radioprotective effect of E. coli endotoxin on hematopoietic stem cells is partially suppressed by inhibiting production of nitric oxide by administering N-omega-nitro-L-arginine].
Lipopolysaccharide of E. coli (LPS) injected to mice one day before the total gamma-irradiation caused a substantial increase in the level of endogeneous colonies formed in the spleen. It is known that this type of endotoxin may result in considerable production of nitric oxide from macrophages in different tissues. Therefore it is possible that the activation of hemopoietic stem cells after LPS-treatment was completely or partially stimulated by nitric oxide, which is the most important physiological mediator, or by action some other mediators (cytokines and growth factors) produced by hemopoietic microenvironment elements in response to the action of nitric oxide. This assumption was checked in experience with combined treatment of mice by LPS and a nonspecific inhibitor of nitric oxide production--N omega-nitro-1-arginine (NA). NA used in high dose (250 mg/kg) reduced partially (approximately by 30%) the LPS-increased level of spleen endogeneous colonies. When LPS was injected to mice 15 minutes after gamma-irradiation, this led to a slight increase in level of spleen colonies. In case when LPS was used together with NA after gamma-irradiation, this increase was still found.
- 25 October 2002
- Vol. 42 (4) , 395-8
[Radioprotective effect of E. coli endotoxin on hematopoietic stem cells is partially suppressed by inhibiting production of nitric oxide by administering N-omega-nitro-L-arginine].
Lipopolysaccharide of E. coli (LPS) injected to mice one day before the total gamma-irradiation caused a substantial increase in the level of endogeneous colonies formed in the spleen. It is known that this type of endotoxin may result in considerable production of nitric oxide from macrophages in different tissues. Therefore it is possible that the activation of hemopoietic stem cells after LPS-treatment was completely or partially stimulated by nitric oxide, which is the most important physiological mediator, or by action some other mediators (cytokines and growth factors) produced by hemopoietic microenvironment elements in response to the action of nitric oxide. This assumption was checked in experience with combined treatment of mice by LPS and a nonspecific inhibitor of nitric oxide production--N omega-nitro-1-arginine (NA). NA used in high dose (250 mg/kg) reduced partially (approximately by 30%) the LPS-increased level of spleen endogeneous colonies. When LPS was injected to mice 15 minutes after gamma-irradiation, this led to a slight increase in level of spleen colonies. In case when LPS was used together with NA after gamma-irradiation, this increase was still found.